Treating SARS-CoV-2 Based Upon the Fleming InflammoThrombotic Response (ITR) & Cardiovascular Disease Theory

This paper discusses the importance of addressing, measuring and treating the infectious, inflammatory and thrombotic tissue effect resulting from the body’s immunologic response to SARS-CoV-2 using methods previously detailed in the medical literature, in an effort to reduce SARS-CoV-2 morbidity and mortality. Successful treatment of SARS-CoV-2 requires addressing each of the four stages of the viral infection including oxygenation, acute cytotoxic immune response, adaptive humoral-antibody response, and viral cellular attachment and replication. Information obtained from the National Clinical Trial NCT04349410 has proven the benefit of treating each of these four factors. A paper detailing the NCT04349410 results has been published elsewhere.